You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Cancer Statistics, 2002
|
|---|---|
| Published in |
CA: A Cancer Journal for Clinicians , February 2009
|
| DOI | 10.3322/canjclin.52.1.23 |
| Pubmed ID | |
| Authors |
Ahmedin Jemal, Andrea Thomas, Taylor Murray, Michael Thun |
| Abstract |
Every year the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival, using National Cancer Institute (NCI) incidence and National Center for Health Statistics (NCHS) mortality data. Incidence and death rates are age adjusted to the 1970 US standard population. It is estimated that 1,284,900 new cases of cancer will be diagnosed and 555,500 people will die from cancer in the United States in the year 2002. From 1992 to 1998, cancer death rates declined in males and females, while cancer incidence rates decreased among males and increased slightly among females. Most notably, African-American men showed the largest decline for both incidence and mortality. Nevertheless, African Americans still carry the highest burden of cancer with later-stage cancer diagnosis and poorer survival compared with whites. Despite the continued decline in cancer death rates, the total number of recorded cancer deaths in the United States continues to increase slightly due to the aging and expanding population. |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Germany | 1 | <1% |
| Brazil | 1 | <1% |
| United Kingdom | 1 | <1% |
| South Africa | 1 | <1% |
| Spain | 1 | <1% |
| Ukraine | 1 | <1% |
| Unknown | 141 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 19% |
| Student > Ph. D. Student | 17 | 11% |
| Student > Master | 15 | 10% |
| Student > Bachelor | 14 | 9% |
| Professor > Associate Professor | 13 | 9% |
| Other | 30 | 20% |
| Unknown | 32 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 26% |
| Agricultural and Biological Sciences | 25 | 17% |
| Biochemistry, Genetics and Molecular Biology | 12 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Immunology and Microbiology | 5 | 3% |
| Other | 23 | 15% |
| Unknown | 39 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2024.
All research outputs
#1,157,222
of 26,017,215 outputs
Outputs from CA: A Cancer Journal for Clinicians
#228
of 1,043 outputs
Outputs of similar age
#2,953
of 114,289 outputs
Outputs of similar age from CA: A Cancer Journal for Clinicians
#6
of 61 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,043 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 80.2. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 114,289 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 61 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.